An Open Label, Single Dose, Randomized, Two-Period, Two-Way Crossover Study to Evaluate the Pharmacokinetics and Bioequivalence of Vycavert Tablets Compared to Norco Tablets in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 07 Feb 2012
At a glance
- Drugs Hydrocodone/paracetamol (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors Pfizer
- 07 Feb 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 07 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jan 2012 Planned End Date changed from 1 Dec 2011 to 1 Feb 2012 as reported by ClinicalTrials.gov.